Skip to main content
. 2023 Jun 5;88:101614. doi: 10.1016/j.seps.2023.101614

Table 15.

Ranking obtained under different methods.

Treatments Rank (R1) obtained using GHPFN Rank (R2) obtained using GHTFN Rank (R3) obtained using GHTrFN
Plasma Exchange 2 2 1
Tocilizumab 4 1 4
Remdesivir 5 4 5
Favipravir 3 3 3
Hydroxychloroquine 1 1 2